A Randomized, Double-Blind, Placebo-Controlled Trial Using Cannabidiol for the Treatment of Painful Diabetic Peripheral Neuropathy of the Feet
Latest Information Update: 30 Mar 2023
At a glance
- Drugs Cannabidiol (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions
- Sponsors Pure Green Pharmaceuticals
Most Recent Events
- 30 Mar 2023 New trial record